Clinical Trial Update: Tocilizumab in COVID-19 Pneumonia (TOCIVID-19) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for tocilizumab in COVID-19 pneumonia (TOCIVID-19) with unknown current status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: National Cancer Institute, Naples | Conditions: COVID-19 Pneumonia | Phase 2 | Status: UNKNOWN